Nov 10, 2022 Independent study demonstrates novel AI-ECG algorithm could provide a cost-effective strategy for improving cardiac risk stratification Southlake, Texas, Nov. 10, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far […]
We sit at the forefront of a brand new era for ECGs. Sound dramatic? That’s because it is. People think of the conventional ECG as something that will diagnose you with heart disease. It isn’t. We’re moving the new era forward. We sit at the forefront of a brand new era for ECGs. Sound dramatic? […]
Data generated by our AI-based technology has been peer reviewed in several prominent medical journals, including @JACC Journals and @ESC_Journals. What were some of the findings? Data generated by our AI-based technology has been peer reviewed in several prominent medical journals, including @JACCJournals and @ESC_Journals. What were some of the findings? 🔊 Our CEO Andrew […]
Do you think home devices like the Apple Watch are going to eat into our potential market share? Think again. These devices are actually hugely beneficial. Our CEO Andrew Simpson explains why. https://twitter.com/i/status/1585606738652368896
Shared by Ken Dropiewski on October 25, 2022 Patent builds on previously granted U.S. patent as well as strengthens and diversifies the IP portfolio and further protects future revenues Southlake, Texas, Oct. 25, 2022 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making […]
Oct 25, 2022 Patent builds on previously granted U.S. patent as well as strengthens and diversifies the IP portfolio and further protects future revenues Southlake, Texas, Oct. 25, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known […]
CEO Andrew Simpson discusses how we’re one of the only companies leading the use of an AI-enabled EKG medical device to make it a far more valuable screening tool. $HSCS CEO Andrew Simpson discusses how we’re one of the only companies leading the use of an AI-enabled EKG medical device to make it a far […]
Oct 20, 2022 Southlake, Texas, Oct. 20, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of AI, today announced it was recognized by MedTech Outlook Magazine […]
Chairman & CEO, Andrew Simpson, Describes AI-based Technology EKG Test and Next Steps for Commercialization
Heart Test Laboratories’ Chairman & CEO, Andrew Simpson, Describes AI-based Technology EKG Test and Next Steps for Commercialization
©2023. ™ Trademark of HeartSciences. Reg. US Pat. & TM off. All Rights Reserved.
MV-WBSTE-001 Rev B
wavECG and wavEKG are trademarks of HeartSciences.
